Jesse McFarland
Director, Bioconjugates & Chemistry Shasqi Inc.
Seminars
Tuesday 24th February 2026
Leveraging Clinical Learnings from SQ3370 to Empower Next Generation Pre-Targeting Using Click Chemistry
3:00 pm
- Clinical safety validates use of click chemistry for therapeutics
- Clinical efficacy demonstrates click chemistry proof-of-concept
- Pre-targeting enables efficacy and safety in preclinical models for a CEACAM5-targeted binder with MMAE payload
